Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05732805
What this trial is testing

A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma

Who this might be right for
MelanomaMelanoma (Skin)Melanoma Stage III+4 more
Biocad 270
Testing effectiveness (Phase 2)Looking for participantsNCT07303803
What this trial is testing

Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus

Who this might be right for
MASH - Metabolic Dysfunction-Associated SteatohepatitisT2DM (Type 2 Diabetes Mellitus)
Shanghai Jiao Tong University School of Medicine 300
Post-approval studies (Phase 4)Active Not RecruitingNCT06860841
What this trial is testing

Effects of D-Chiro-Inositol Combined with Metformin on Insulin Resistance in People with Overweight or Obesity and T2DM

Who this might be right for
Type 2 DiabetesOverweight and Obese Adults
Campus Bio-Medico University 16
Large-scale testing (Phase 3)Looking for participantsNCT05305794
What this trial is testing

Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes"

Who this might be right for
Double Diabetes
Centre Hospitalier Universitaire Dijon 76
Large-scale testing (Phase 3)UnknownNCT01245166
What this trial is testing

A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
The Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mgPlus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks inSubjects With Type 2 Diabetes Mellitus.
Lotus Pharmaceutical
Large-scale testing (Phase 3)Study completedNCT00855166
What this trial is testing

Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 182
Post-approval studies (Phase 4)Study completedNCT02589639
What this trial is testing

Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 269
Large-scale testing (Phase 3)Study completedNCT01217892
What this trial is testing

Evaluation of Dapagliflozin Taken Twice-daily

Who this might be right for
Type 2 Diabetes
AstraZeneca 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT07502495
What this trial is testing

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets

Who this might be right for
Type 2 Diabetes
Biomea Fusion Inc. 64
Early research (Phase 1)Study completedNCT05814107
What this trial is testing

Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 DiabetesOverweight or Obesity
Carmot Australia First Pty Ltd 94
Large-scale testing (Phase 3)Study completedNCT00614939
What this trial is testing

Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment

Who this might be right for
Type 2 Diabetes
AstraZeneca 572
Not applicableUnknownNCT02683902
What this trial is testing

The Effect of Hypocaloric Diet Associated With tDCS on Weight Loss and Metabolic Profile

Who this might be right for
PrediabetesObesityWeight Loss+2 more
Hospital de Clinicas de Porto Alegre 20
Testing effectiveness (Phase 2)Study completedNCT02470039
What this trial is testing

Trial to Compare NNC0123-0000-0338 in a Tablet Formulation and Insulin Glargine in Subjects With Type 2 Diabetes Currently Treated With Oral Antidiabetic Therapy

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 50
Not applicableStudy completedNCT07330700
What this trial is testing

Effects of Marching Exercise With Cognitive Training on Physical, Cognitive Function, and Autonomic Cardiovascular Responses in Older Adults With Type 2 Diabetes Mellitus

Who this might be right for
Type2 Diabetes MellitusAutonomic Nervous System Imbalance
Chonticha Kaewjoho 60
Testing effectiveness (Phase 2)Ended earlyNCT02915263
What this trial is testing

The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes

Who this might be right for
Diabetes ComplicationsDiabetes MellitusDiabetic Neuropathies
Beth Israel Deaconess Medical Center 13
Not applicableStudy completedNCT03062592
What this trial is testing

FFAR Agonist on Incretins, Insulin, Lipids and Inflammation

Who this might be right for
Type2 Diabetes MellitusObesity
Odense University Hospital 8
Not applicableStudy completedNCT00703209
What this trial is testing

Study on the Role of Decompression of Lower Extremity Nerves for the Treatment of Patients With Symptomatic Diabetic Neuropathy With Chronic Nerve Compression

Who this might be right for
Painful Diabetic Neuropathy
University of Texas Southwestern Medical Center 138
Large-scale testing (Phase 3)Study completedNCT00044447
What this trial is testing

Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione

Who this might be right for
Diabetes Mellitus, Non-Insulin-Dependent
Sanofi 170
Post-approval studies (Phase 4)Study completedNCT02288273
What this trial is testing

Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.

Who this might be right for
Type 2 Diabetes
AstraZeneca 239
Testing effectiveness (Phase 2)Looking for participantsNCT05650229
What this trial is testing

Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease

Who this might be right for
Primary Mitochondrial Disease
Pharming Technologies B.V. 180
Next Page
220